On Friday, iBio Inc (NASDAQ: IBIO) was 9.82% up from the session before settling in for the closing price of $0.73. A 52-week range for IBIO has been $0.64 – $6.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -18.92% over the past five years. When this article was written, the company’s average yearly earnings per share was at 59.06%. With a float of $15.58 million, this company’s outstanding shares have now reached $16.52 million.
Let’s look at the performance matrix of the company that is accounted for 19 employees. In terms of profitability, gross margin is 298.4%, operating margin of -4478.67%, and the pretax margin is -4389.33%.
iBio Inc (IBIO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward iBio Inc stocks. The insider ownership of iBio Inc is 5.67%, while institutional ownership is 15.78%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.
iBio Inc (IBIO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 59.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.01% during the next five years compared to 57.55% growth over the previous five years of trading.
iBio Inc (NASDAQ: IBIO) Trading Performance Indicators
You can see what iBio Inc (IBIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 34.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.33, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of iBio Inc (IBIO)
iBio Inc (NASDAQ: IBIO) saw its 5-day average volume 0.63 million, a negative change from its year-to-date volume of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 15.47%. Additionally, its Average True Range was 0.19.
During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 2.62%, which indicates a significant decrease from 10.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.03% in the past 14 days, which was lower than the 165.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4896, while its 200-day Moving Average is $2.6127. Nevertheless, the first resistance level for the watch stands at $0.8386 in the near term. At $0.8777, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9370. If the price goes on to break the first support level at $0.7402, it is likely to go to the next support level at $0.6809. The third support level lies at $0.6418 if the price breaches the second support level.
iBio Inc (NASDAQ: IBIO) Key Stats
There are 16,519K outstanding shares of the company, which has a market capitalization of 13.21 million. As of now, sales total 230 K while income totals -24,910 K. Its latest quarter income was 200 K while its last quarter net income were -4,360 K.
